Max Robotics — Global Service Robot Directory + US Certification

About

Giuseppe Fornarini is a leading oncologist whose research has fundamentally advanced the understanding and treatment of genitourinary cancers, with a particular focus on prostate cancer. His major contributions lie in the clinical application of PSMA-PET imaging, where he has pioneered efforts to standardize its interpretation among urologists and oncologists, directly improving diagnostic accuracy for disease staging. Beyond imaging, Fornarini has been instrumental in developing novel therapeutic strategies, including the use of PARP inhibitors and immunotherapy combinations for metastatic prostate cancer, helping to define new standards of care for patients with aggressive disease. His work is highly impactful, with several of his key publications on targeted therapies and biomarker-driven treatment approaches garnering hundreds of citations. Notably, he has led prospective, multicenter trials that have reshaped clinical guidelines, and his research has been recognized with prestigious awards from international oncology societies. Fornarini’s career is defined by a commitment to translating complex molecular insights into tangible improvements in patient survival and quality of life, making him a pivotal figure in the field of urologic oncology.